Advertisement HEPI gets PAZ patent issuance notification - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

HEPI gets PAZ patent issuance notification

Health Enhancement Products (HEPI) has received notification of patent issuance regarding its proprietary algal extract ProAlgaZyme (PAZ).

The patent, titled ‘Composition and Use of Phyto-Percolate for the Treatment of Disease,’ describes the general makeup of PAZ and its ability to address a variety of common maladies, such as inflammation, oxidative stress and cholesterol regulation.

HEPI director John Gorman said that the patent is another layer of protection for the processes and bioactive compounds that are integral to PAZ and its future derivatives.

"Earlier this year, we filed two patents for regulation of healthy cholesterol management and we intend to build on that IP portfolio and also expect to be filing additional patents in the very near future," Gorman said.

Health Enhancement Products is a health & wellness company engaged in the development of a product comprised of natural compounds that can be used as a dietary supplement and food additive.